相似文献
1
Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes.
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6605-10. doi: 10.1073/pnas.121180398. Epub 2001 May 29.
2
Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli.
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3185-9. doi: 10.1073/pnas.89.8.3185.
3
Phenotypic conversion of drug-resistant bacteria to drug sensitivity.
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8468-72. doi: 10.1073/pnas.94.16.8468.
4
Cleavage by RNase P of gene N mRNA reduces bacteriophage lambda burst size.
Nucleic Acids Res. 1996 Mar 1;24(5):835-42. doi: 10.1093/nar/24.5.835.
5
[Ribonuclease P--an example of catalytic RNA activity].
Postepy Biochem. 1992;38(3):112-22.
6
Design of short external guide sequences (EGSs) for cleavage of target molecules with RNase P.
Nucleic Acids Symp Ser. 1997(36):19-21.
7
[Experimental study on phenotypic conversion of clinical chloromycetin-resistant strains of E. coli to drug-sensitive strains by using EGS technique in vitro].
Zhonghua Yi Xue Za Zhi. 2004 Aug 2;84(15):1294-8.
8
Suppression of loss-of-function mutations in Escherichia coli ribonuclease P RNA (M1 RNA) by a specific base-pair disruption.
J Mol Biol. 1993 Mar 5;230(1):11-4. doi: 10.1006/jmbi.1993.1120.
9
Mapping RNA-protein interactions in ribonuclease P from Escherichia coli using disulfide-linked EDTA-Fe.
J Mol Biol. 2000 Feb 11;296(1):19-31. doi: 10.1006/jmbi.1999.3443.
10
Artificial regulation of gene expression in Escherichia coli by RNase P.
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11115-9. doi: 10.1073/pnas.92.24.11115.
引用本文的文献
1
Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection.
Viruses. 2024 Jul 25;16(8):1196. doi: 10.3390/v16081196.
2
RNase P-Mediated Sequence-Specific Cleavage of RNA by Engineered External Guide Sequences.
Biomolecules. 2015 Nov 9;5(4):3029-50. doi: 10.3390/biom5043029.
3
Targeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum.
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11935-40. doi: 10.1073/pnas.1515864112. Epub 2015 Sep 8.
4
External guide sequence technology: a path to development of novel antimicrobial therapeutics.
Ann N Y Acad Sci. 2015 Sep;1354(1):98-110. doi: 10.1111/nyas.12755. Epub 2015 Apr 9.
5
(Non-)translational medicine: targeting bacterial RNA.
Front Genet. 2013 Nov 8;4:230. doi: 10.3389/fgene.2013.00230. eCollection 2013.
6
Inhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZ.
PLoS One. 2012;7(10):e47690. doi: 10.1371/journal.pone.0047690. Epub 2012 Oct 23.
7
Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes.
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16582-7. doi: 10.1073/pnas.1112561108. Epub 2011 Sep 26.
8
Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA.
RNA. 2010 Nov;16(11):2218-25. doi: 10.1261/rna.2256610. Epub 2010 Sep 3.
9
Generation of an external guide sequence library for a reverse genetic screen in Caenorhabditis elegans.
BMC Biotechnol. 2009 May 20;9:47. doi: 10.1186/1472-6750-9-47.
10
Inactivation of expression of several genes in a variety of bacterial species by EGS technology.
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8163-8. doi: 10.1073/pnas.0903491106. Epub 2009 Apr 30.
本文引用的文献
1
Microbial genome sequencing.
Nature. 2000 Aug 17;406(6797):799-803. doi: 10.1038/35021244.
2
Molecular mechanisms that confer antibacterial drug resistance.
Nature. 2000 Aug 17;406(6797):775-81. doi: 10.1038/35021219.
3
Inactivation of gene expression using ribonuclease P and external guide sequences.
Methods Enzymol. 2000;313:442-56. doi: 10.1016/s0076-6879(00)13028-9.
4
DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities.
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):29-43. doi: 10.1016/s0167-4781(98)00126-2.
5
Phenotypic conversion of drug-resistant bacteria to drug sensitivity.
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8468-72. doi: 10.1073/pnas.94.16.8468.
6
Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.
Antimicrob Agents Chemother. 1996 Apr;40(4):1009-13. doi: 10.1128/AAC.40.4.1009.
7
DNA topoisomerases.
Annu Rev Biochem. 1996;65:635-92. doi: 10.1146/annurev.bi.65.070196.003223.
8
Mechanism of action of quinolones against Escherichia coli DNA gyrase.
Antimicrob Agents Chemother. 1993 Apr;37(4):839-45. doi: 10.1128/AAC.37.4.839.
9
A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex.
Antimicrob Agents Chemother. 1993 Jan;37(1):126-7. doi: 10.1128/AAC.37.1.126.
10
Artificial regulation of gene expression in Escherichia coli by RNase P.
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11115-9. doi: 10.1073/pnas.92.24.11115.
Zotero 插件